Your browser doesn't support javascript.
loading
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial.
Baek, Soo Yeon; Noh, Woo Chul; Ahn, Sei-Hyun; Kim, Hyun-Ah; Ryu, Jai Min; Kim, Seung Il; Lee, Eun-Gyeong; Im, Seock-Ah; Jung, Yongsik; Park, Min Ho; Park, Kyong Hwa; Kang, Su Hwan; Jeong, Joon; Park, Eunhwa; Kim, Sung Yong; Lee, Min Hyuk; Kim, Lee Su; Lim, Woosung; Kim, Seonok; Kim, Hee Jeong.
Affiliation
  • Baek SY; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Noh WC; Department of Surgery, Ajou University School of Medicine, Suwon, South Korea.
  • Ahn SH; Department of Surgery, Konkuk University Medical Center, Seoul, South Korea.
  • Kim HA; Department of Surgery, Ewha Womans University College of Medicine, Ewha Womans University Mokdong Hospital, Seoul, South Korea.
  • Ryu JM; Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, South Korea.
  • Kim SI; Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Lee EG; Division of Breast Surgery, Department of Surgery, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Im SA; Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
  • Jung Y; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Park MH; Department of Surgery, Ajou University School of Medicine, Suwon, South Korea.
  • Park KH; Department of Surgery, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Gwangju, South Korea.
  • Kang SH; Department of Internal Medicine, Division of Medical Oncology/Hematology, Korea University Anam Hospital, Seoul, South Korea.
  • Jeong J; Yeungnam University College of Medicine, Daegu, South Korea.
  • Park E; Division of Breast Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim SY; Dong-A University Hospital, Dong-A University College of Medicine, Busan, South Korea.
  • Lee MH; Department of Surgery, Soonchunhyang University Cheonan Hospital, Cheonan, South Korea.
  • Kim LS; Department of Surgery, Soonchunhyang University Hospital, Seoul, South Korea.
  • Lim W; Department of Surgery, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, South Korea.
  • Kim S; Department of Surgery, Ewha Womans University College of Medicine, Ewha Womans University Mokdong Hospital, Seoul, South Korea.
  • Kim HJ; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, South Korea.
J Clin Oncol ; 41(31): 4864-4871, 2023 11 01.
Article in En | MEDLINE | ID: mdl-37607321
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms Limits: Female / Humans Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms Limits: Female / Humans Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: